Stay updated on FT538 with Daratumumab in AML Clinical Trial
Sign up to get notified when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.

Latest updates to the FT538 with Daratumumab in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new revision entry 'Revision: v3.5.4' to the study record history and removed the previous 'Revision: v3.5.3'. This update updates the history to reflect the latest revision of the study record.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA site/interface revision indicator on the record history page was updated from version v3.5.2 to v3.5.3. This represents a background system/version change rather than a modification to the clinical trial record itself.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed in the study history.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check108 days agoChange DetectedThe revision history shows a new revision label (v3.4.2) replacing the previous v3.4.1; this is a cosmetic update with no substantive content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to FT538 with Daratumumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT538 with Daratumumab in AML Clinical Trial page.